首页/数据集/Dataset from A Phase II Study of BIBW 2992 Administration in Patients With Hormone Refractory Metastatic Breast Cancer

Dataset from A Phase II Study of BIBW 2992 Administration in Patients With Hormone Refractory Metastatic Breast Cancer

NIAID Data Ecosystem2026-05-02 收录

癌症靶向治疗

临床疗效评估

数据链接：

https://doi.org/10.25934/00003525 数据链接链接失效反馈

官方服务：

资源简介：

Progression-free rate after 16 weeks of BIBW 2992 administration in association with letrozole

应用场景：

创建时间：

2024-11-26

癌症靶向治疗

RAS信号通路抑制

Crystal structure of BRAF/MEK1 complex with NST-628 and an active RAF dimer Descriptor: 1,2-ETHANEDIOL, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Dual specificity mitogen-activated protein kinase kina

Protein Data Bank Japan2024-07-10 更新60

First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials

癌症靶向治疗

药物疗效比较

Purpose A variety of targeted drug were developed and proved effective and safe in clinical trials. Our study aims to compare the efficacies and safety of different targeted drugs in advanced hepatoce

NIAID Data Ecosystem50

Development of Aptamer-DNAzyme Based Metal-Nucleic Acid Frameworks for Gastric Cancer therapy

核酸适配体药物递送

癌症靶向治疗

All data from source data

NIAID Data Ecosystem20

Depletion of Nrf2 in pancreatic cancer cells shifts arginine metabolism into the phosphocreatine energy system. Depletion of Nrf2 in pancreatic cancer cells shifts arginine metabolism into the phosphocreatine energy system

癌细胞重编程

癌症靶向治疗

Depletion of Nrf2 leads to an increase in cellular ROS, reduced glutathione and thiols, and profound reprogramming of metabolism. Unbiased transcriptome analyses show that key enzymes of glycolysis, p

NIAID Data Ecosystem60

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

临床疗效评估

医疗质量指标

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

Figshare2022-11-02 更新30